Brokers Set Expectations for HealthEquity, Inc.'s Q1 2025 Earnings (NASDAQ:HQY)

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Stock analysts at Zacks Research lifted their Q1 2025 earnings per share (EPS) estimates for shares of HealthEquity in a research note issued on Tuesday, April 9th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.45 for the quarter, up from their prior forecast of $0.43. The consensus estimate for HealthEquity's current full-year earnings is $2.11 per share. Zacks Research also issued estimates for HealthEquity's Q4 2025 earnings at $0.59 EPS, FY2025 earnings at $2.04 EPS, Q1 2026 earnings at $0.54 EPS, Q2 2026 earnings at $0.59 EPS, Q3 2026 earnings at $0.67 EPS, Q4 2026 earnings at $0.72 EPS and FY2026 earnings at $2.52 EPS.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%.

Several other research analysts also recently commented on HQY. Raymond James raised their price objective on HealthEquity from $90.00 to $95.00 and gave the stock an "outperform" rating in a research note on Wednesday, December 13th. BTIG Research lifted their target price on HealthEquity from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, March 20th. JMP Securities assumed coverage on HealthEquity in a research report on Thursday, April 4th. They issued a "mkt outperform" rating and a $101.00 price target for the company. Barrington Research restated an "outperform" rating and set a $100.00 target price on shares of HealthEquity in a research note on Friday, March 22nd. Finally, Royal Bank of Canada upped their target price on HealthEquity from $90.00 to $92.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $96.17.

HealthEquity Stock Down 1.0 %

HQY traded down $0.81 during trading on Thursday, reaching $80.49. The stock had a trading volume of 681,328 shares, compared to its average volume of 613,180. HealthEquity has a one year low of $48.86 and a one year high of $84.49. The company has a market capitalization of $6.91 billion, a price-to-earnings ratio of 127.03, a P/E/G ratio of 1.30 and a beta of 0.53. The stock's 50 day moving average is $80.69 and its two-hundred day moving average is $73.96. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43.

Institutional Trading of HealthEquity

Large investors have recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC boosted its position in HealthEquity by 4.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 3,115 shares of the company's stock worth $207,000 after buying an additional 140 shares during the period. Xponance Inc. increased its stake in HealthEquity by 1.2% during the 4th quarter. Xponance Inc. now owns 12,269 shares of the company's stock valued at $813,000 after purchasing an additional 147 shares in the last quarter. Fifth Third Bancorp increased its stake in HealthEquity by 36.5% during the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company's stock valued at $44,000 after purchasing an additional 161 shares in the last quarter. Metropolitan Life Insurance Co NY grew its stake in shares of HealthEquity by 3.6% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 5,190 shares of the company's stock worth $320,000 after acquiring an additional 179 shares in the last quarter. Finally, Sheets Smith Wealth Management grew its stake in shares of HealthEquity by 2.5% in the 3rd quarter. Sheets Smith Wealth Management now owns 7,921 shares of the company's stock worth $579,000 after acquiring an additional 191 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the business's stock in a transaction on Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the transaction, the executive vice president now owns 49,996 shares of the company's stock, valued at approximately $3,999,680. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the business's stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total value of $199,920.00. Following the transaction, the executive vice president now directly owns 49,996 shares in the company, valued at $3,999,680. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Jon Kessler sold 33,765 shares of the company's stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares in the company, valued at $10,106,739.35. The disclosure for this sale can be found here. Insiders sold 71,322 shares of company stock valued at $5,682,895 in the last quarter. Company insiders own 2.70% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.